Skip to main content
. 2010 Jul;83(1):90–96. doi: 10.4269/ajtmh.2010.09-0286

Table 2.

Treatment response regarding combined antimalarial treatment, Colombia

Response CQ and SP* AQ and SP MQ and SP AS and SP AS and AQ AS and MQ AS, MQ, and PQ
ETF, no. (%) 1 (1.6) 1 (1.1) 0 0 0 0 0
LCF, no. (%) 10 (15.6) 1 (1.1) 0 0 0 0 0
LPF, no. (%) 0 0 1 (1.1) 2 (2.0) 0 0 0
SCPR, no. (%) 53 (82.8) 89 (97.8) 91 (98.9) 96 (98.0) 52 (100) 25 (100) 25 (100)
Total 64 91 92 98 52 25 25
*

CQ = chloroquine; SP = sulfadoxine-pyrimethamine; AQ = amodiaquine; MQ = mefloquine; AS = artesunate; PQ = primaquine; ETF = early therapeutic failure; LCF = late clinical failure; LPF = late parasitologic failure; SCPR = suitable clinical and parasitologic response.